# MacAndrews & Forbes Holdings

MacAndrews & Forbes Holdings is a Private Equity based in New York, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** 31 East 62nd Street, New York, NY 10065, United States
- **Assets under management:** Undisclosed
- **Website:** www.macandrewsandforbes.com

## Regulatory record

- **Reports private funds:** No

## About

Our core strategy is to focus our business lines on strong market positions, high quality management with vertical expertise, recognized grow

## Sectors

- FinTech
- Biotechnology
- Healthcare Services
- Industrial Tech

## People

- Ronald O. Perelman — Chairman and Chief Executive Officer

## Questions

### Who runs investment decisions at MacAndrews & Forbes?

Ronald O. Perelman, as Chairman and CEO, is the ultimate decision-maker for all acquisitions and divestitures. The firm operates as his personal holding company, making his conviction the sole driver of the portfolio. The website references a management team that supports operations, but executive names and titles beyond Perelman are not publicly listed.

### Is MacAndrews & Forbes a traditional private equity fund?

No. It is a wholly-owned holding company that deploys Ronald Perelman's personal capital without limited partners or a fixed fund life. This permanent-capital structure allows it to hold businesses indefinitely and sustain companies through long regulatory or development cycles, as seen with SIGA Technologies and vTv Therapeutics.

### Does MacAndrews & Forbes invest in funds or only directly into companies?

The firm's public disclosures describe only direct ownership of a small number of operating businesses. There is no mention of making fund commitments to external managers, investing in third-party private equity funds, or participating in club deals alongside other investors.

### What investment stages does MacAndrews & Forbes target?

The firm acquires established businesses and also maintains controlling interests in early- to clinical-stage biotechnology companies. Vericast represents a mature, revenue-generating financial-services platform, while vTv Therapeutics remains clinical-stage. This blend of cash-flowing assets and development-stage biotech is an atypical mix for a personal holding company.

## Related profiles

- [MAC Fund](https://altss.com/profile/mac-fund)
- [Machame](https://altss.com/profile/machame)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/macandrews-and-forbes-holdings

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology